← FDA DRUG APPROVALS

FDA ANDA · ANDA090613

TORSEMIDE

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA090613
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-22
LATEST ACTION
2012-11-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TORSEMIDEDiscontinued
TORSEMIDE 100MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 10MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 20MG · TABLET · ORAL
TORSEMIDEDiscontinued
TORSEMIDE 5MG · TABLET · ORAL

Approval history

2012-11-07Labeling · Supplement 6 · standardAP
2011-03-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →